*
Tracker finds more than $35 billion in profit, sales,
other hits
*
Toyota's ( TM ) $9.5 billion forecast is the biggest hit
*
Trump's threat of new China tariffs renews uncertainty
By Deborah Mary Sophia and Arpan Varghese
Oct 20 (Reuters) - Global companies have flagged more
than $35 billion in costs from U.S. tariffs heading into
third-quarter earnings, but many are lowering their initial
forecasts as new trade deals reduce exposure to President Donald
Trump's levies.
Trump's trade war has hiked U.S. tariffs to their highest
levels since the 1930s, and the president has regularly
threatened more duties, but overall, the fog that paralyzed many
businesses is clearing, allowing executives to forecast costs
and make plans - including some price hikes.
Companies expected a combined financial hit of $21.0 billion
to $22.9 billion for 2025, with an impact of nearly $15 billion
calculated for 2026, according to a Reuters analysis of hundreds
of corporate statements, regulatory filings and earnings calls
between July 16 and September 30.
The total of more than $35 billion compares with $34 billion
tallied in May, shortly after Trump's "Liberation Day" tariffs
in April rattled global supply chains. But the trajectory masks
a shift: the increase is largely due to Toyota's ( TM ) $9.5
billion estimate. Many other companies have lowered their
earlier worst-case forecasts after Trump reached lower-rate
trade deals with the EU and Japan. The figures combine annual
and partial-year estimates from an overlapping group of firms.
Both groups include about 60 firms.
French spirits makers Remy Cointreau and Pernod
Ricard both lowered estimates of tariff pain after
the EU deal, while Sony ( SONY ) in August cut its forecast.
Trump also carved out exceptions, with only about a third of
Brazil's exports facing a 50% tariff, for instance.
"Tariffs are getting clearer and clearer. And we believe that
tariffs will be just another variable of our business equation
that we need to be ready to manage, and we will," Stellantis ( STLA )
CEO Antonio Filosa told Reuters in a mid-October
interview, introducing new details of a $13 billion, four-year
investment in U.S. manufacturing. Stellantis ( STLA ) in July warned of a
1.5 billion-euro hit from U.S. tariffs this year.
"I think there is this sense that we reached a kind of
landing point with some of the bilateral trade deals," said
International Chamber of Commerce Deputy Secretary General
Andrew Wilson.
"But there will continue to be much greater complexity and
this massive uncertainty."
Case in point: Trump earlier this month floated the idea of
additional 100% tariffs on China. On Friday, he said the
proposed tariffs would not be sustainable, and blamed Beijing
for the latest tensions in trade talks between the two
countries.
CONSUMER AND MANUFACTURING HIT HARDEST
S&P 500 companies are projected to show an earnings growth
rate of 9.3% in the July-September period, a decline from 13.8%
in the second quarter, according to LSEG data. Much of that is
on the back of the U.S. IT sector, driven by AI investment.
Europe's Stoxx 600 is expected to clock 0.5% growth, down from
4% in the previous quarter.
The pain is concentrated on companies that depend on
countries that do not have trade deals.
Nike ( NKE ), heavily dependent on suppliers in Vietnam and
other Asian countries, raised its tariff impact estimate late
last month to $1.5 billion from $1 billion. In Europe, Tefal
kitchen-ware maker SEB recently cut its profit
outlook, citing weaker demand as customers adopted a
wait-and-see attitude partly due to tariffs, while H&M
cautioned that U.S. tariffs on imports would weigh more heavily
on margins in the quarter through November.
"We are cautious about the U.S. heading into the fourth
quarter, both connected to the impact of tariffs on the gross
margin but equally also the consumer sentiment," H&M CEO Daniel
Erver told Reuters. "We can see the price increases."
Price increases are the most frequent effect of tariffs
cited by companies in the Reuters tracker.
Carmakers including Ford, Stellantis ( STLA ), Volkswagen
and Toyota ( TM ) collectively have reported billions in tariff-related
costs. Ford, for instance, is expecting a cumulative $3 billion
impact.
Still, optimism has ticked up among automakers and auto parts
suppliers as Trump has moved toward significant tariff relief
for U.S. auto production that could effectively eliminate many
of the costs that have hit top car companies.
Drug makers also have started rolling out deals on drug pricing
and manufacturing that are tied to U.S. tariff exemptions.
Pfizer ( PFE ) and AstraZeneca ( AZN ) have led the way, and
others are expected to follow.